70 FR 224 pg. 70621 - Agency Information Collection Activities; Announcement of Officeof Management and Budget Approval; Regulations for In VivoRadiopharmaceuticals Used for Diagnosis and Monitoring
Type: NOTICEVolume: 70Number: 224Page: 70621
Docket number: [Docket No. 2005N-0153]
FR document: [FR Doc. 05-23039 Filed 11-21-05; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005N-0153]
Agency Information Collection Activities; Announcement of Officeof Management and Budget Approval; Regulations for In VivoRadiopharmaceuticals Used for Diagnosis and Monitoring
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) isannouncing that a collection of information entitled "Regulations ForIn Vivo Radiopharmaceuticals Used For Diagnosis and Monitoring" hasbeen approved by the Office of Management and Budget (OMB) under thePaperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Karen Nelson, Officeof Management Programs (HFA-250), Food and Drug Administration, 5600Fishers Lane, Rockville, MD 20857,301-827-1482.
SUPPLEMENTARY INFORMATION:
In the FederalRegister of May 3, 2005 (70 FR 22887), the agency announced that theproposed information collection had been submitted to OMB for review andclearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, anda person is not required to respond to, a collection of information unlessit displays a currently valid OMB control number. OMB has now approved theinformation collection and has assigned OMB control number 0910-0409.The approval expires on October 31, 2008. A copy of the supportingstatement for this information collection is available on the Internet at http://www.fda.gov/ohrms/dockets .
Dated: November 15, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-23039 Filed 11-21-05; 8:45 am]
BILLING CODE 4160-01-S